|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2025―Mar―04 |
Low dose of hydroxychloroquine is associated with reduced COVID-19 mortality: a multicenter study in China |
Wu He, Ke Xu, Yongcui Yan, Gen Li, Bo Yu, Junfang Wu, et al. (+3) Kaineng Zhong, Da Zhou, Dao Wen Wang |
2 |
[GO] |
2024―Jul―03 |
Acquired immune thrombotic thrombocytopenic purpura (TTP) associated with inactivated COVID-19 vaccine CoronaVac |
Zhangbiao Long, Suyu Jiang, Honglei Xin, Lu Zhang, Ruinan Lu, Fengqi Liu, et al. (+16) Yong Xu, Linv Wang, Jun Wang, Xuezhong Zhang, Hui Liao, Jinning Shi, Xue Yan, Xiang Zhu, Ruonan Shao, Zijian Li, Yilin Zhu, Han Yan, Jiao Wu, Chao Fang, Xiaodong Xi, Xiaofeng Shi |
3 |
[GO] |
2024―Apr―02 |
Emergence of SARS and COVID-19 and preparedness for the next emerging disease X |
Ben Hu, Hua Guo, Haorui Si, Zhengli Shi |
4 |
[GO] |
2024―Apr―02 |
Trajectory of COVID-19 response and management strategy in China: scientific rationale driven strategy adjustments |
Zeyu Zhang, Yue Yan, Lina Zhao, Yizhou Bian, Ning Zhao, You Wu, et al. (+2) Dahai Zhao, Zongjiu Zhang |
5 |
[GO] |
2024―Feb―01 |
Revisiting China’s response to coronavirus disease 2019 |
Guangbiao Zhou, Saijuan Chen, Zongjiu Zhang, Zhu Chen |
6 |
[GO] |
2024―Jan―02 |
Epidemiology, pathogenesis, and management of Coronavirus disease 2019-associated stroke |
Lu Liu, Chenxia Zhou, Huimin Jiang, Huimin Wei, Yifan Zhou, Chen Zhou, Xunming Ji |
7 |
[GO] |
2023―Dec―29 |
Practice and principle of traditional Chinese medicine for the prevention and treatment of COVID-19 |
Linhua Zhao, Chuanxi Tian, Yingying Yang, Huifang Guan, Yu Wei, Yuxin Zhang, et al. (+7) Xiaomin Kang, Ling Zhou, Qingwei Li, Jing Ma, Li Wan, Yujiao Zheng, Xiaolin Tong |
8 |
[GO] |
2023―Dec―29 |
Cytokine storm and translating IL-6 biology into effective treatments for COVID-19 |
Tiantian Li, Dongsheng Wang, Haiming Wei, Xiaoling Xu |
9 |
[GO] |
2023―Dec―29 |
Pathogen evolution, prevention/control strategy and clinical features of COVID-19: experiences from China |
Dong Wei, Yusang Xie, Xuefei Liu, Rong Chen, Min Zhou, Xinxin Zhang, Jieming Qu |
10 |
[GO] |
2023―Dec―16 |
Innovation-driven trend shaping COVID-19 vaccine development in China |
Yuntao Zhang, Yuxiu Zhao, Hongyang Liang, Ying Xu, Chuge Zhou, Yuzhu Yao, et al. (+2) Hui Wang, Xiaoming Yang |
11 |
[GO] |
2023―Nov―18 |
A pilot study on Paxlovid therapy for hemodialysis patients with severe acute respiratory syndrome coronavirus 2 infections |
Xu Hao, Zhiyao Bao, Ranran Dai, Xiaojing Wu, Xin Li, Muyin Zhang, et al. (+10) Hao Li, Lili Xu, Panpan Qiao, Xuefei Liu, Weiting Hu, Ze Zhang, Jie Fang, Min Zhou, Weiming Wang, Jieming Qu |
12 |
[GO] |
2023―Jul―12 |
Protection of inactivated vaccine against SARS-CoV-2 infections in patients with comorbidities: a prospective cohort study |
Kanchana Ngaosuwan, Kamonwan Soonklang, Chawin Warakul, Chirayu Auewarakul, Nithi Mahanonda |
13 |
[GO] |
2023―Jun―27 |
Effectiveness of inactivated COVID-19 vaccine against the severity of Omicron variant |
Hao Wang, Li Liu, Tangchun Wu |
14 |
[GO] |
2023―Mar―31 |
Primary assessment of the diversity of Omicron sublineages and the epidemiologic features of autumn/winter 2022 COVID-19 wave in Chinese mainland |
Gang Lu, Yun Ling, Minghao Jiang, Yun Tan, Dong Wei, Lu Jiang, et al. (+12) Shuting Yu, Fangying Jiang, Shuai Wang, Yao Dai, Jinzeng Wang, Geng Wu, Xinxin Zhang, Guoyu Meng, Shengyue Wang, Feng Liu, Xiaohong Fan, Saijuan Chen |
15 |
[GO] |
2023―Mar―23 |
Host protection against Omicron BA.2.2 sublineages by prior vaccination in spring 2022 COVID-19 outbreak in Shanghai |
Ziyu Fu, Dongguo Liang, Wei Zhang, Dongling Shi, Yuhua Ma, Dong Wei, et al. (+16) Junxiang Xi, Sizhe Yang, Xiaoguang Xu, Di Tian, Zhaoqing Zhu, Mingquan Guo, Lu Jiang, Shuting Yu, Shuai Wang, Fangyin Jiang, Yun Ling, Shengyue Wang, Saijuan Chen, Feng Liu, Yun Tan, Xiaohong Fan |
16 |
[GO] |
2023―Feb―04 |
Neutralization against SARS-CoV-2 Delta/Omicron variants and B cell response after inactivated vaccination among COVID-19 convalescents |
Hao Wang, Yu Yuan, Bihao Wu, Mingzhong Xiao, Zhen Wang, Tingyue Diao, et al. (+21) Rui Zeng, Li Chen, Yanshou Lei, Pinpin Long, Yi Guo, Xuefeng Lai, Yuying Wen, Wenhui Li, Hao Cai, Lulu Song, Wei Ni, Youyun Zhao, Kani Ouyang, Jingzhi Wang, Qi Wang, Li Liu, Chaolong Wang, An Pan, Xiaodong Li, Rui Gong, Tangchun Wu |
17 |
[GO] |
2022―Dec―29 |
Management and operation of extra-large Fangcang hospitals: experience and lessons from containing the highly contagious SARS-CoV-2 Omicron in Shanghai, China |
Yun Xian, Chenhao Yu, Minjie Chen, Lin Zhang, Xinyi Zheng, Shijian Li, et al. (+17) Erzhen Chen, Zhongwan Chen, Weihua Chen, Chaoying Wang, Qingrong Xu, Tao Han, Weidong Ye, Wenyi Xu, Xu Zhuang, Yu Zheng, Min Chen, Jun Qin, Yu Feng, Shun Wei, Yiling Fan, Zhiruo Zhang, Junhua Zheng |
18 |
[GO] |
2022―Sep―24 |
Seroprevalence of influenza viruses in Shandong, Northern China during the COVID-19 pandemic |
Chuansong Quan, Zhenjie Zhang, Guoyong Ding, Fengwei Sun, Hengxia Zhao, Qinghua Liu, et al. (+11) Chuanmin Ma, Jing Wang, Liang Wang, Wenbo Zhao, Jinjie He, Yu Wang, Qian He, Michael J. Carr, Dayan Wang, Qiang Xiao, Weifeng Shi |
19 |
[GO] |
2022―Mar―08 |
Integrated analysis of gut microbiome and host immune responses in COVID-19 |
Xiaoguang Xu, Wei Zhang, Mingquan Guo, Chenlu Xiao, Ziyu Fu, Shuting Yu, et al. (+6) Lu Jiang, Shengyue Wang, Yun Ling, Feng Liu, Yun Tan, Saijuan Chen |
20 |
[GO] |
2022―Mar―07 |
SARS-CoV-2 variants, immune escape, and countermeasures |
Yi Zhang, Haocheng Zhang, Wenhong Zhang |
21 |
[GO] |
2022―Feb―28 |
SARS-CoV-2 vaccine research and immunization strategies for improved control of the COVID-19 pandemic |
Yiming Shao, Yingqi Wu, Yi Feng, Wenxin Xu, Feng Xiong, Xinxin Zhang |
22 |
[GO] |
2022―Feb―22 |
PathogenTrack and Yeskit: tools for identifying intracellular pathogens from single-cell RNA-sequencing datasets as illustrated by application to COVID-19 |
Wei Zhang, Xiaoguang Xu, Ziyu Fu, Jian Chen, Saijuan Chen, Yun Tan |
23 |
[GO] |
2022―Feb―04 |
Early assessment of the safety and immunogenicity of a third dose (booster) of COVID-19 immunization in Chinese adults |
Yuntao Zhang, Yunkai Yang, Niu Qiao, Xuewei Wang, Ling Ding, Xiujuan Zhu, et al. (+5) Yu Liang, Zibo Han, Feng Liu, Xinxin Zhang, Xiaoming Yang |
24 |
[GO] |
2022―Feb―04 |
A review of the safety and efficacy of current COVID-19 vaccines |
Zehong Huang, Yingying Su, Tianying Zhang, Ningshao Xia |
25 |
[GO] |
2021―Aug―31 |
COVID-19: why not learn from the past? |
Elena Zocchi, Giuseppe Terrazzano |
26 |
[GO] |
2021―Aug―13 |
Clinical characteristics and risk factors of COVID-19 patients with chronic hepatitis B: a multi-center retrospective cohort study |
Jing Wang, Zequn Lu, Meng Jin, Ying Wang, Kunming Tian, Jun Xiao, et al. (+15) Yimin Cai, Yanan Wang, Xu Zhang, Tao Chen, Zhi Yao, Chunguang Yang, Renli Deng, Qiang Zhong, Xiongbo Deng, Xin Chen, Xiang-ping Yang, Gonghong Wei, Zhihua Wang, Jianbo Tian, Xiao-ping Chen |
27 |
[GO] |
2021―Jul―09 |
Renin-angiotensin system inhibitor is associated with the reduced risk of all-cause mortality in COVID-19 among patients with/without hypertension |
Huai-yu Wang, Suyuan Peng, Zhanghui Ye, Pengfei Li, Qing Li, Xuanyu Shi, et al. (+13) Rui Zeng, Ying Yao, Fan He, Junhua Li, Liu Liu, Shuwang Ge, Xianjun Ke, Zhibin Zhou, Gang Xu, Ming-hui Zhao, Haibo Wang, Luxia Zhang, Erdan Dong |
28 |
[GO] |
2021―Apr―28 |
Comparison of the clinical features and therapeutics of COVID-19 in cardio-cerebrovascular disease (CCVD) and non-CCVD patients |
Yu Wang, Lan Li, Yuanjiang Pan, Yu He, Zuhua Chen, Yunhao Xun, et al. (+5) Yuhan Xu, Yilei Guo, Jiehong Yang, Jianchun Guo, Haitong Wan |
29 |
[GO] |
2021―Apr―28 |
Effects of Shuanghuanglian oral liquids on patients with COVID-19: a randomized, open-label, parallel-controlled, multicenter clinical trial |
Li Ni, Zheng Wen, Xiaowen Hu, Wei Tang, Haisheng Wang, Ling Zhou, et al. (+21) Lujin Wu, Hong Wang, Chang Xu, Xizhen Xu, Zhichao Xiao, Zongzhe Li, Chene Li, Yujian Liu, Jialin Duan, Chen Chen, Dan Li, Runhua Zhang, Jinliang Li, Yongxiang Yi, Wei Huang, Yanyan Chen, Jianping Zhao, Jianping Zuo, Jianping Weng, Hualiang Jiang, Dao Wen Wang |
30 |
[GO] |
2021―Apr―28 |
Neutralizing monoclonal antibodies present new prospects to treat SARS-CoV-2 infections |
Rongtao Lai, Tianhui Zhou, Xiaogang Xiang, Jie Lu, Haiguang Xin, Qing Xie |
31 |
[GO] |
2021―Mar―23 |
Clinical characteristics and risk factors for mortality in cancer patients with COVID-19 |
Junnan Liang, Guannan Jin, Tongtong Liu, Jingyuan Wen, Ganxun Li, Lin Chen, et al. (+7) Wei Wang, Yuwei Wang, Wei Liao, Jia Song, Zeyang Ding, Xiao-ping Chen, Bixiang Zhang |
32 |
[GO] |
2021―Mar―22 |
Endothelial dysfunction in COVID-19 calls for immediate attention: the emerging roles of the endothelium in inflammation caused by SARS-CoV-2 |
Weijian Hang, Chen Chen, Xin A. Zhang, Dao Wen Wang |
33 |
[GO] |
2021―Mar―09 |
Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial |
Dongsheng Wang, Binqing Fu, Zhen Peng, Dongliang Yang, Mingfeng Han, Min Li, et al. (+22) Yun Yang, Tianjun Yang, Liangye Sun, Wei Li, Wei Shi, Xin Yao, Yan Ma, Fei Xu, Xiaojing Wang, Jun Chen, Daqing Xia, Yubei Sun, Lin Dong, Jumei Wang, Xiaoyu Zhu, Min Zhang, Yonggang Zhou, Aijun Pan, Xiaowen Hu, Xiaodong Mei, Haiming Wei, Xiaoling Xu |
34 |
[GO] |
2021―Jan―29 |
Degradation of SARS-CoV-2 receptor ACE2 by the E3 ubiquitin ligase Skp2 in lung epithelial cells |
Guizhen Wang, Qun Zhao, Hui Zhang, Fan Liang, Chen Zhang, Jun Wang, et al. (+8) Zhenyin Chen, Ran Wu, Hong Yu, Beibei Sun, Hua Guo, Ruie Feng, Kaifeng Xu, Guangbiao Zhou |
35 |
[GO] |
2020―Oct―26 |
Clinical manifestations and pathogen characteristics in children admitted for suspected COVID-19 |
Xiaofang Cai, Hanlan Jiang, Simin Zhang, Shengying Xia, Wenhui Du, Yaoling Ma, et al. (+2) Tao Yu, Wenbin Li |
36 |
[GO] |
2020―Oct―24 |
Persistence of humoral and cellular immune response after SARS-CoV-2 infection: opportunities and challenges |
Tangchun Wu |
37 |
[GO] |
2020―Oct―05 |
Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection |
Yun Tan, Feng Liu, Xiaoguang Xu, Yun Ling, Weijin Huang, Zhaoqin Zhu, et al. (+9) Mingquan Guo, Yixiao Lin, Ziyu Fu, Dongguo Liang, Tengfei Zhang, Jian Fan, Miao Xu, Hongzhou Lu, Saijuan Chen |
38 |
[GO] |
2020―Sep―14 |
Clinical features and the traditional Chinese medicine therapeutic characteristics of 293 COVID-19 inpatient cases |
Zixin Shu, Yana Zhou, Kai Chang, Jifen Liu, Xiaojun Min, Qing Zhang, et al. (+9) Jing Sun, Yajuan Xiong, Qunsheng Zou, Qiguang Zheng, Jinghui Ji, Josiah Poon, Baoyan Liu, Xuezhong Zhou, Xiaodong Li |
39 |
[GO] |
2020―Sep―14 |
Chinese herbal medicine reduces mortality in patients with severe and critical Coronavirus disease 2019: a retrospective cohort study |
Guohua Chen, Wen Su, Jiayao Yang, Dan Luo, Ping Xia, Wen Jia, et al. (+14) Xiuyang Li, Chuan Wang, Suping Lang, Qingbin Meng, Ying Zhang, Yuhe Ke, An Fan, Shuo Yang, Yujiao Zheng, Xuepeng Fan, Jie Qiao, Fengmei Lian, Li Wei, Xiaolin Tong |
40 |
[GO] |
2020―Aug―29 |
Taizhou’s COVID-19 prevention and control experience with telemedicine features |
Cenyi Shao, Shijian Li, Feng Zhu, Dahai Zhao, Hui Shao, Haixiao Chen, Zhiruo Zhang |
41 |
[GO] |
2020―Aug―06 |
Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19 |
Lingling Tang, Yingan Jiang, Mengfei Zhu, Lijun Chen, Xiaoyang Zhou, Chenliang Zhou, et al. (+13) Peng Ye, Xiaobei Chen, Baohong Wang, Zhenyu Xu, Qiang Zhang, Xiaowei Xu, Hainv Gao, Xiaojun Wu, Dong Li, Wanli Jiang, Jingjing Qu, Charlie Xiang, Lanjuan Li |
42 |
[GO] |
2020―Aug―06 |
Successful management of seven cases of critical COVID-19 with early noninvasive-invasive sequential ventilation algorithm and bundle pharmacotherapy |
Mian Peng, Xueyan Liu, Jinxiu Li, Di Ren, Yongfeng Liu, Xi Meng, et al. (+4) Yansi Lyu, Ronglin Chen, Baojun Yu, Weixiong Zhong |
43 |
[GO] |
2020―Jul―23 |
Traditional Chinese medicine for combating COVID-19 |
Kaixian Chen, Hongzhuan Chen |
44 |
[GO] |
2020―Jul―10 |
The role played by traditional Chinese medicine in preventing and treating COVID-19 in China |
Qingwei Li, Han Wang, Xiuyang Li, Yujiao Zheng, Yu Wei, Pei Zhang, et al. (+6) Qiyou Ding, Jiaran Lin, Shuang Tang, Yikun Zhao, Linhua Zhao, Xiaolin Tong |
45 |
[GO] |
2020―Jul―03 |
Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis |
Jiuyang Xu, Chaolin Huang, Guohui Fan, Zhibo Liu, Lianhan Shang, Fei Zhou, et al. (+14) Yeming Wang, Jiapei Yu, Luning Yang, Ke Xie, Zhisheng Huang, Lixue Huang, Xiaoying Gu, Hui Li, Yi Zhang, Yimin Wang, Frederick G. Hayden, Peter W. Horby, Bin Cao, Chen Wang |
46 |
[GO] |
2020―Jun―03 |
Linking key intervention timings to rapid declining effective reproduction number to quantify lessons against COVID-19 |
Zhihang Peng, Wenyu Song, Zhongxing Ding, Quanquan Guan, Xu Yang, Qiaoqiao Xu, et al. (+2) Xu Wang, Yankai Xia |
47 |
[GO] |
2020―May―28 |
Estimation of reproduction numbers of COVID-19 in typical countries and epidemic trends under different prevention and control scenarios |
Chen Xu, Yinqiao Dong, Xiaoyue Yu, Huwen Wang, Lhakpa Tsamlag, Shuxian Zhang, et al. (+11) Ruijie Chang, Zezhou Wang, Yuelin Yu, Rusi Long, Ying Wang, Gang Xu, Tian Shen, Suping Wang, Xinxin Zhang, Hui Wang, Yong Cai |
48 |
[GO] |
2020―May―14 |
Organ function support in patients with coronavirus disease 2019: Tongji experience |
Yong Li, Fan He, Ning Zhou, Jia Wei, Zeyang Ding, Luyun Wang, et al. (+5) Peng Chen, Shuiming Guo, Binhao Zhang, Xiaoning Wan, Wei Zhu |
49 |
[GO] |
2020―May―04 |
Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain |
Zhengqian Li, Taotao Liu, Ning Yang, Dengyang Han, Xinning Mi, Yue Li, et al. (+4) Kaixi Liu, Alain Vuylsteke, Hongbing Xiang, Xiangyang Guo |
50 |
[GO] |
2020―Apr―23 |
Thanks to all medical workers fighting against COVID-19 |
Xiao-ping Chen |
51 |
[GO] |
2020―Apr―21 |
Advances in COVID-19: the virus, the pathogenesis, and evidence-based control and therapeutic strategies |
Guangbiao Zhou, Saijuan Chen, Zhu Chen |
52 |
[GO] |
2020―Apr―13 |
Clinical characteristics of 19 neonates born to mothers with COVID-19 |
Wei Liu, Jing Wang, Wenbin Li, Zhaoxian Zhou, Siying Liu, Zhihui Rong |
53 |
[GO] |
2020―Apr―11 |
Phase- and epidemic region-adjusted estimation of the number of coronavirus disease 2019 cases in China |
Ruijie Chang, Huwen Wang, Shuxian Zhang, Zezhou Wang, Yinqiao Dong, Lhakpa Tsamlag, et al. (+15) Xiaoyue Yu, Chen Xu, Yuelin Yu, Rusi Long, Ning-Ning Liu, Qiao Chu, Ying Wang, Gang Xu, Tian Shen, Suping Wang, Xiaobei Deng, Jinyan Huang, Xinxin Zhang, Hui Wang, Yong Cai |
54 |
[GO] |
2020―Apr―02 |
Coronavirus disease 2019 (COVID-19): a clinical update |
Min Zhou, Xinxin Zhang, Jieming Qu |
55 |
[GO] |
2020―Mar―25 |
COVID-19 containment: China provides important lessons for global response |
Shuxian Zhang, Zezhou Wang, Ruijie Chang, Huwen Wang, Chen Xu, Xiaoyue Yu, et al. (+4) Lhakpa Tsamlag, Yinqiao Dong, Hui Wang, Yong Cai |
56 |
[GO] |
2020―Mar―24 |
Protecting healthcare personnel from 2019-nCoV infection risks: lessons and suggestions |
Zhiruo Zhang, Shelan Liu, Mi Xiang, Shijian Li, Dahai Zhao, Chaolin Huang, Saijuan Chen |
57 |
[GO] |
2020―Mar―23 |
Molecular network-based intervention brings us closer to ending the HIV pandemic |
Xiaoxu Han, Bin Zhao, Minghui An, Ping Zhong, Hong Shang |
58 |
[GO] |
2020―Mar―20 |
2019 novel Coronavirus outbreak: a quiz or final exam? |
Jiuyang Xu, Yijun Chen, Hao Chen, Bin Cao |
59 |
[GO] |
2020―Mar―14 |
Back to the spring of Wuhan: facts and hope of COVID-19 outbreak |
Guangbiao Zhou, Saijuan Chen, Zhu Chen |
60 |
[GO] |
2020―Mar―13 |
Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19 in Wuhan |
Li Ni, Ling Zhou, Min Zhou, Jianping Zhao, Dao Wen Wang |
61 |
[GO] |
2020―Mar―13 |
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection |
Xin Zou, Ke Chen, Jiawei Zou, Peiyi Han, Jie Hao, Zeguang Han |
62 |
[GO] |
2020―Mar―12 |
China’s local governments are combating COVID-19 with unprecedented responses - from a Wenzhou governance perspective |
Fanghua Gong, Yong Xiong, Jian Xiao, Li Lin, Xiaodong Liu, Dezhong Wang, Xiaokun Li |
|